Clinical trial
PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.
NCT03121235 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.
- Lead sponsor
- Erasmus Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2017
- Completion date
- March 20, 2022
- Enrollment
- 320 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
aspergillosis, invasive pulmonary